The DIA has announced that its early registration fee reduction for next month's EuroMeeting will end on Tuesday February 11.
The DIA has announced that its early registration fee reduction for next month’s EuroMeeting will end on Tuesday February 11. The standard member’s registration for the meeting will rise from 1700 euros to 1850 euros after February 11, according to the organizers.
Also, a new co-chair has been appointed for the congress: Christa Wirthumer-Hoche, who recently became Head of the Austrian Medicines Agency.
The conference will take place in Vienna, Austria, from 25 to 27 March 2014. It is likely to attract over 3,000 delegates from more than 50 countries. It brings together professionals from the biopharmaceutical industry, contract research and service organizations, academic research centers, regulatory agencies and health ministries, as well as delegates from patient organizations.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.